Home/ Stocks/ COYA

Coya Therapeutics, Inc. Common Stock

COYA XNAS

$4.11 -0.08 (-2.00%) ▼ 15-min delayed

Open

$4.23

High

$4.28

Low

$4.06

Volume

165.7K

Market Cap

$96.41M

About Coya Therapeutics, Inc. Common Stock

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 8 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$3.56M	$-2,115,831	$-0.13
Q2 2025	$163.6K	$-6,094,977	$-0.36
Q1 2025	$257.9K	$-7,306,757	$-0.44
FY 2024	$3.55M	$-14,880,787	$-0.98

Related Market News

No specific coverage for COYA yet. Check out our latest market news or earnings calendar.

Get COYA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Coya Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.